An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
|Effective start/end date
|9/4/13 → 8/1/16
- VERTEX PHARMACEUTICALS INCORPORATED
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.